Ameritas Investment Partners
IMNM icon

Ameritas Investment Partners’s Immunome IMNM Stock Holding History

Ameritas Investment Partners’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
9,566
+1,211
+14% +$25.9K 0.01% 1385
2026
Q1 		$183K Buy
8,355
+750
+10% +$16.7K 0.01% 1323
2025
Q4 		$163K Buy
7,605
+432
+6% +$7.58K 0.01% 1379
2025
Q3 		$84K Hold
7,173
– – ﹤0.01% 1789
2025
Q2 		$66.7K Hold
7,173
– – ﹤0.01% 2008
2025
Q1 		$48.3K Buy
7,173
+2,137
+42% +$20.5K ﹤0.01% 2122
2024
Q4 		$53.5K Hold
5,036
– – ﹤0.01% 2141
2024
Q3 		$73.6K Hold
5,036
– – ﹤0.01% 1964
2024
Q2 		$60.9K Buy
+5,036
New +$78.8K ﹤0.01% 2034
2021
Q2 		– Sell
-175
Closed -$6K – 3145
2021
Q1 		$6K Hold
175
– – ﹤0.01% 2980
2020
Q4 		$2K Buy
+175
New +$2.04K ﹤0.01% 3047

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Ameritas Investment Partners's IMNM Position: Q2 2026 in Review

Ameritas Investment Partners increased its Immunome (IMNM) stake by 14% in Q2 2026, buying an estimated $25.9K and bringing the position to 9,566 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #1385.

Ameritas Investment Partners first reported a position in IMNM in Q4 2020 and has held it in 11 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Ameritas Investment Partners held 9,566 shares of Immunome worth $203K as of Q2 2026.
  • Ameritas Investment Partners bought 1,211 Immunome shares in Q2 2026, an estimated $25.9K.
  • Immunome made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1385 holding.
  • Ameritas Investment Partners first reported a position in Immunome in Q4 2020 and has held it in 11 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.